In a rather representative study, researchers loaded dextran based nanoparticles loaded with the chemotherapeutic drug irinotecan and combined them with engineered phages targeting the tumor-promoting bacterium Fn in experiments using phage-guided nanotechnology to modulate the gut microbiota in mouse models of CRC (Kannen et al., 2019). This evidence concerns the gene FN1 and colorectal carcinoma.